Drugs News and Research

RSS

Drug makers push for more time to pay half-off discount on drugs

Drug makers want 60 days instead of 15 to pay a half-off discount for branded drugs in a Medicare Part D coverage gap, Inside Health Policy reports. The Centers for Medicare and Medicaid Services also intends to ask drug makers to pay disputed amounts ahead of a decision about whether the company must pay the discount.

4 Jun 2010

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Given promptly, the antiviral drug oseltamivir (Tamiflu) appears safe and effective for infants hospitalized with influenza, reports a study in the June issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

4 Jun 2010

Today's OpEds: New Republic and National Review on health law; Conservative bloggers blast CBO numbers

The shouting war over health reform's effect on the budget got a little louder today when the director of the Office of Management and Budget, Peter Orszag, pushed back at conservative bloggers who are saying federal officials were disingenuous about the real costs of the law (Kate Steadman, 6/2).

4 Jun 2010

MicroStockProfit.com releases investment report featuring Rexahn Pharmaceuticals

MicroStockProfit.com announces an investment report featuring Rexahn Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

3 Jun 2010

Phase 1B clinical study with PMX-60056 meets safety and efficacy endpoints: PolyMedix

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.

3 Jun 2010

Local anesthetics may have potential therapeutic effects on IBD

Inflammatory bowel disease (IBD) is a disease of the gastrointestinal tract, mainly the intestines that may occur in the people who have genetic potential with a contribution of environmental factors.

3 Jun 2010

Study provides personalized strategies to boost AIAA compliance in breast cancer patients

Aromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs.

3 Jun 2010

Study suggests inexperienced medical staff make fatal medication errors

Are new medical residents a threat to patients? According to Dr. David Phillips and Gwendolyn Barker from the University of California, San Diego in the US, fatal medication errors peak in July in teaching hospitals in particular, which coincides with the yearly influx of new medical residents who are given increased responsibility for patient care.

3 Jun 2010

Nanosponge delivery system more effective at reducing tumor growth than direct injection: Study

When loaded with an anticancer drug, a delivery system based on a novel material called nanosponge is three to five times more effective at reducing tumor growth than direct injection.

3 Jun 2010

Motavizumab should not be licensed for marketing: FDA Antiviral Drugs Advisory Committee

MedImmune today announced that the U.S. Food and Drug Administration's Antiviral Drugs Advisory Committee has voted 14 to 3 to recommend that motavizumab should not be licensed for marketing regarding the prevention of serious respiratory syncytial virus disease in high-risk infants.

3 Jun 2010

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.

3 Jun 2010

U.N. Secretary-General calls for African nations to invest 15% of national budgets to fight HIV/AIDS

During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.

3 Jun 2010

Researchers describe chain of molecular events that increase one's risk of skin cancer

As people head to the beach this summer, very few if any, really know how likely they are to develop skin cancer from their outdoor fun. That's about to change, thanks to a new discovery by an international team of scientists that makes it possible for doctors to access people's personal risk for skin cancer.

3 Jun 2010

Regulators miss deadline on medical loss ratios: Other implementation developments continue to emerge

Insurance regulators have missed an early deadline to set specific rules meant to ensure that insurers devote 80 to 85 percent of premium dollars to medical care, the so-called "medical loss ratio."

3 Jun 2010

Insulin pills to manage diabetes are finally moving ahead in clinical trials

After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are finally moving ahead in clinical trials and a step-closer to the medicine cabinet. That's among the topics highlighted in a two-part cover story on drug manufacturing in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

3 Jun 2010

New concept: Hotel 'medical-concierge' program

The Ritz-Carlton's medical-concierge program, now expanded after a trial run to include hospitals and medical facilities throughout the Philadelphia area, aims to provide a pampering bridge between the hospital room and the patient's home. The concierge does not perform medical procedures or administer drugs.

3 Jun 2010

Academic detailing technique may help doctors follow treatment guidelines

Researchers often get frustrated when doctors fail to adopt treatment guidelines backed by the best evidence-based research.

3 Jun 2010

Fraud roundup: LA hospital workers investigated; Guilty pleas in Texas and N.J. cases; Fla. candidate defends his actions

Los Angeles County officials are investigating allegations that Olive View-UCLA Medical Center staff accepted gifts from nursing home employees in exchange for placing Medi-Cal and Medicare patients at their facilities, a possible violation of the county's code of ethics, as well as state and federal anti-kickback laws.

3 Jun 2010

CPAP treatment may be a better option for preterm infants

A national study involving a UT Southwestern Medical Center neonatologist provides new insight into how much oxygen preterm infants should receive as well as the optimal way to deliver it to them.

3 Jun 2010

DBS procedure effective for treating Parkinson's disease

Studies have shown that a "brain pacemaker" called deep brain stimulation (DBS) is an effective treatment for Parkinson's disease.

3 Jun 2010

Drugs News and Research

Drug makers push for more time to pay half-off discount on drugs

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Today's OpEds: New Republic and National Review on health law; Conservative bloggers blast CBO numbers

MicroStockProfit.com releases investment report featuring Rexahn Pharmaceuticals

Phase 1B clinical study with PMX-60056 meets safety and efficacy endpoints: PolyMedix

Local anesthetics may have potential therapeutic effects on IBD

Study provides personalized strategies to boost AIAA compliance in breast cancer patients

Study suggests inexperienced medical staff make fatal medication errors

Nanosponge delivery system more effective at reducing tumor growth than direct injection: Study

Motavizumab should not be licensed for marketing: FDA Antiviral Drugs Advisory Committee

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

U.N. Secretary-General calls for African nations to invest 15% of national budgets to fight HIV/AIDS

Researchers describe chain of molecular events that increase one's risk of skin cancer

Regulators miss deadline on medical loss ratios: Other implementation developments continue to emerge

Insulin pills to manage diabetes are finally moving ahead in clinical trials

New concept: Hotel 'medical-concierge' program

Academic detailing technique may help doctors follow treatment guidelines

Fraud roundup: LA hospital workers investigated; Guilty pleas in Texas and N.J. cases; Fla. candidate defends his actions

CPAP treatment may be a better option for preterm infants

DBS procedure effective for treating Parkinson's disease

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News